A new remedy Zolgensma by Novartis Company is designed to replace long-term therapy for children with spinal muscular atrophy. The remedy is intended for a single use. Clinical trials that involved 36 children aged 2 weeks to 8 months have shown the effectiveness of such approach. The children demonstrated the acceleration of the development of motor skills (they better held their heads and sat). It should be reminded that spinal muscular atrophy often causes paralysis, breathing problems and death in the first months of a child’s life.

Elderly people taking proton pump inhibitors, which are usually prescribed for the treatment of acid-related diseases of the gastrointestinal tract, are at high risk of developing dementia. This is indicated by recent studies described in the Pharmaceutical Journal.

A group of scientists from Britain and Australia are researching bacteria causing scarlet fever. According to the scientists, they are quite ready to start work on a vaccine, The Sydney Morning Herald reports. We are talking about group A streptococcus. This pathogen being one of the most deadly bacteria causes not only scarlet fever.

More than 500 colleagues and partners of the company from Ukraine and abroad took part in the celebrations. The president of the company, Jain Pradeep Kumar, personally opened the ceremony

According to "Vesti", glioblastoma is one of the most common and deadly types of brain cancer in adults.

Borosan composition contains 7 medicinal plants

Cholix can be recommended for normalization of the biliary tract, liver and digestion.

On April 12, Provisor club school launched an all-Ukrainian educational program in Kharkiv.

On February 27, 2019, a scientific and practical seminar “Multidisciplinary approach to the treatment of internal diseases” was held in the teleconference format.

On February 27, 2019, a scientific and practical seminar “Multidisciplinary approach to the treatment of internal diseases” was held in the teleconference format.